[1]
Nascimento, I.J. dos S.; Cavalcanti, M. de A.T.; de Moura, R.O. Exploring N-myristoyltransferase as a promising drug target against parasitic neglected tropical diseases. Eur. J. Med. Chem., 2023, 258, 115550.
[2]
De Souza, M.; Medeiros, D.C.; de Moura, R.O.; dos Santos Nascimento, I.J. Pharmacokinetic limitations to overcome and enable K777 as a potential drug against chagas disease. Curr. Pharm. Des., 2023, 29, 2359-2360.
[3]
dos Santos Nascimento, I.J.; de Aquino, T.M.; da Silva-Júnior, E.F. Cruzain and rhodesain inhibitors: last decade of advances in seeking for new compounds against American and African trypanosomiases. Curr. Top. Med. Chem., 2021, 21, 1871-1899.
[4]
dos Santos Nascimento, I.J.; da Silva Rodrigues, É.E.; da Silva, M.F.; de Araújo-Júnior, J.X.; de Moura, R.O. Advances in computational methods to discover new NS2B-NS3 inhibitors useful against dengue and zika viruses. Curr. Top. Med. Chem., 2022, 22, 2435-2462.
[5]
Saha, A. Pushpa; Moitra, S.; Basak, D.; Brahma, S.; Mondal, D.; Molla, S.H.; Samadder, A.; Nandi, S. Targeting cysteine proteases and their inhibitors to combat trypanosomiasis. Curr. Med. Chem., 2024, 31(16), 2135-2169.
[6]
Giroud, M.; Kuhn, B.; Haap, W. Drug discovery efforts to identify novel treatments for neglected tropical diseases - cysteine protease inhibitors. Curr. Med. Chem., 2024, 31(16), 2170-2194.
[7]
Akram, M.; Hameed, S.; Hassan, A.; Khan, K. Development in the inhibition of dengue proteases as drug targets. Curr. Med. Chem., 2024, 31(16), 2195-2233.
[8]
Hernández González, J.E.; Salas-Sarduy, E.; Alvarez, L.H.; Valiente, P.A.; Arni, R.K.; Pascutti, P.G. Three decades targeting falcipains to develop antiplasmodial agents: What have we learned and what can be done next? Curr. Med. Chem., 2024, 31(16), 2234-2263.
Related Journals
Current Pharmaceutical Design
Current Topics in Medicinal Chemistry
Current Respiratory Medicine Reviews
Infectious Disorders - Drug Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets
Anti-Infective Agents
Coronaviruses
Recent Advances in Inflammation & Allergy Drug Discovery
Current Probiotics
